| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $47.1M | +15.5% |
| Cost of Revenue | $35.2M | +25.7% |
| Gross Profit | $11.9M | -7.0% |
| R&D Expense | $121K | +9.0% |
| SG&A Expense | $11.7M | +27.3% |
| Operating Income | $83K | -97.6% |
| Pre-tax Income | $45K | -98.7% |
| Income Tax | $296K | -60.2% |
| Net Income | -$252K |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $851K | -73.3% |
| Accounts Receivable | $7.6M | +92.0% |
| Inventory | $2.9M | +141.9% |
| Current Assets | $11.6M | +31.1% |
| Total Assets | $30.0M | +113.8% |
| Current Liabilities | $9.0M | +122.1% |
| Total Liabilities | $21.9M | +282.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $910K | -75.4% |
| Capital Expenditures | $862K | +105.6% |
| Investing Cash Flow | -$11.3M | -2393.9% |
| Financing Cash Flow | $8.0M | +1883.6% |
| Free Cash Flow | $47K | -98.6% |
| -106.2% |
| EPS (Basic) | -$0.01 | -108.3% |
| EPS (Diluted) | -$0.01 | -108.3% |
| Stockholders' Equity |
| $8.1M |
| -2.4% |